Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation.

What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

However, a third drug also FDA-approved for weight loss ... should talk with their doctor about whether a GLP-1 drug can help them lose weight.

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...

Three GLP-1 drugs appear to work best at promoting weight loss Tirzepatide (Zepbound) and semaglutide (Wegovy) are effective, researchers said A third not-yet-approved drug, retatrutide ...